On January 4, 2022 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported that the Company will present at the virtual H.C. Wainwright BioConnect Conference, January 10 – 13, 2022 (Press release, Hookipa Biotech, JAN 4, 2022, https://ir.hookipapharma.com/news-releases/news-release-details/hookipa-pharma-present-hc-wainwright-bioconnect-conference [SID1234598074]). The presentation will be available beginning at 7:00 AM EST on Monday, January 10.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast of the presentation will be available within the Investors & Media section of HOOKIPA’s website at View Source An archived replay will be accessible for 30 days following the event.